Tendolkar AV - Search Results

1

Differential absorption of amoxicillin from the human small and large intestine.

Barr WH, Zola EM, Candler EL, Hwang SM, Tendolkar AV, Shamburek R, Parker B, Hilty MD. Barr WH, et al. Among authors: tendolkar av. Clin Pharmacol Ther. 1994 Sep;56(3):279-85. doi: 10.1038/clpt.1994.138. Clin Pharmacol Ther. 1994. PMID: 7924123 Clinical Trial.

2

Single-dose interaction study of diprafenone HCl and propranolol HCl in healthy volunteers.

Hinderling PH, Tendolkar A, Dee CM, Barr WH, Seiberling M, Duerr H. Hinderling PH, et al. J Clin Pharmacol. 1995 Jul;35(7):721-9. doi: 10.1002/j.1552-4604.1995.tb04113.x. J Clin Pharmacol. 1995. PMID: 7560253 Clinical Trial.

3

A pharmacokinetic evaluation of 14C-labeled afovirsen sodium in patients with genital warts.

Crooke ST, Grillone LR, Tendolkar A, Garrett A, Fratkin MJ, Leeds J, Barr WH. Crooke ST, et al. Clin Pharmacol Ther. 1994 Dec;56(6 Pt 1):641-6. doi: 10.1038/clpt.1994.189. Clin Pharmacol Ther. 1994. PMID: 7995006

4

Evaluation of the effects of a high-fat meal on the oral bioavailability of a single dose of preladenant in healthy subjects.

Cutler DL, Tendolkar A, Grachev ID. Cutler DL, et al. J Clin Pharmacol. 2012 Nov;52(11):1698-703. doi: 10.1177/0091270011428321. Epub 2011 Dec 13. J Clin Pharmacol. 2012. PMID: 22167566 Clinical Trial.

5

Safety, tolerability and pharmacokinetics after single and multiple doses of preladenant (SCH420814) administered in healthy subjects.

Cutler DL, Tendolkar A, Grachev ID. Cutler DL, et al. J Clin Pharm Ther. 2012 Oct;37(5):578-87. doi: 10.1111/j.1365-2710.2012.01349.x. Epub 2012 Jun 7. J Clin Pharm Ther. 2012. PMID: 22676397 Clinical Trial.

6

Preladenant, a selective adenosine A₂A receptor antagonist, is not associated with QT/QTc prolongation.

Wang Z, Xuan F, Lin WH, Troyer MD, Tendolkar A, Cutler DL. Wang Z, et al. Eur J Clin Pharmacol. 2013 Oct;69(10):1761-7. doi: 10.1007/s00228-013-1541-5. Epub 2013 Jul 16. Eur J Clin Pharmacol. 2013. PMID: 23857248 Clinical Trial.

7

The Clinical Pharmacology of Elotuzumab.

Passey C, Sheng J, Mora J, Tendolkar A, Robbins M, Dodge R, Roy A, Bello A, Gupta M. Passey C, et al. Clin Pharmacokinet. 2018 Mar;57(3):297-313. doi: 10.1007/s40262-017-0585-6. Clin Pharmacokinet. 2018. PMID: 28779463 Review.

8

A Phase I/II Open-Label Study of Nivolumab in Previously Treated Advanced or Recurrent Nasopharyngeal Carcinoma and Other Solid Tumors.

Ma Y, Fang W, Zhang Y, Yang Y, Hong S, Zhao Y, Tendolkar A, Chen L, Xu D, Sheng J, Zhao H, Zhang L. Ma Y, et al. Oncologist. 2019 Jul;24(7):891-e431. doi: 10.1634/theoncologist.2019-0284. Epub 2019 May 2. Oncologist. 2019. PMID: 31048330 Free PMC article. Clinical Trial.

9

A Phase I Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Ipilimumab in Chinese Patients with Select Advanced Solid Tumors.

Ma Y, Fang W, Zhao H, Bathena SP, Tendolkar A, Sheng J, Zhang L. Ma Y, et al. Oncologist. 2021 Apr;26(4):e549-e566. doi: 10.1002/onco.13577. Epub 2020 Nov 11. Oncologist. 2021. PMID: 33105036 Free PMC article. Clinical Trial.

10

Pharmacokinetics and Safety of Elotuzumab Combined With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma and Various Levels of Renal Impairment: Results of a Phase Ib Study.

Berdeja J, Jagannath S, Zonder J, Badros A, Kaufman JL, Manges R, Gupta M, Tendolkar A, Lynch M, Bleickardt E, Paliwal P, Vij R. Berdeja J, et al. Clin Lymphoma Myeloma Leuk. 2016 Mar;16(3):129-38. doi: 10.1016/j.clml.2015.12.007. Epub 2015 Dec 21. Clin Lymphoma Myeloma Leuk. 2016. PMID: 26795075 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters